Mozart Therapeutics, the leading developer of CD8 Treg network modulators for the treatment of autoimmune disease, today ...

Non-cardiotoxic anthracycline demonstrates activity where traditional chemotherapies have historically failed, supporting potential expansion of ...

Intralesional nivolumab seems effective for reducing the size of precancerous oral lesions, according to a study presented at ...

Scientific Advisory Board (SAB) includes experts in the development and approved T-cell engager therapies, supporting CAPTN-3’s advancement ...

U.S. Rep. Gabe Evans (R-CO) will face a Libertarian challenger this November in his run for reelection in Colorado’s 8th ...

SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.

While modern life includes many conveniences, humans are still incessantly exposed to a variety of metabolic stresses we have ...

While modern life includes many conveniences, humans are still incessantly exposed to a variety of metabolic stresses we have ...

Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line ...

A new UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma ...

In the past decade, immune checkpoint inhibitors (ICIs) have dramatically changed cancer treatment, significantly improving ...